Christopher Kenney
Direttore Tecnico/Scientifico/R&S presso XENON PHARMACEUTICALS INC.
Patrimonio netto: - $ in data 30/06/2024
Posizioni attive di Christopher Kenney
| Società | Posizione | Inizio | Fine |
|---|---|---|---|
| XENON PHARMACEUTICALS INC. | Direttore Tecnico/Scientifico/R&S | 23/08/2021 | - |
Storia della carriera di Christopher Kenney
Precedenti posizioni note di Christopher Kenney
| Società | Posizione | Inizio | Fine |
|---|---|---|---|
Cadent Therapeutics, Inc.
 Cadent Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Cadent Therapeutics, Inc. develops novel small molecule therapeutics to treat schizophrenia and other cognitive disorders. It focuses on modulating synaptic plasticity, the mechanism through which the brain builds and evolves the synaptic networks that carry out cognitive functions such as learning and memory. The company was founded by Kollol Pal, Frank S. Menniti, and Bertrand Leo Chenard in 2010 and is headquartered in Cambridge, MA. | Direttore Tecnico/Scientifico/R&S | 01/01/2019 | 01/12/2020 |
| ACORDA THERAPEUTICS, INC. | Direttore Tecnico/Scientifico/R&S | 01/01/2016 | 01/01/2019 |
| Biotie Therapies, Inc. | Direttore Tecnico/Scientifico/R&S | 01/01/2013 | 01/01/2016 |
Statistiche
Distribuzione geografica
| Stati Uniti | 4 |
| Canada | 2 |
Posizioni
| Chief Tech/Sci/R&D Officer | 4 |
Settori
| Health Technology | 4 |
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Società collegate
| Società quotate in Borsa | 2 |
|---|---|
| XENON PHARMACEUTICALS INC. | Health Technology |
| ACORDA THERAPEUTICS, INC. | Health Technology |
| Aziende private | 2 |
|---|---|
Cadent Therapeutics, Inc.
Cadent Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Cadent Therapeutics, Inc. develops novel small molecule therapeutics to treat schizophrenia and other cognitive disorders. It focuses on modulating synaptic plasticity, the mechanism through which the brain builds and evolves the synaptic networks that carry out cognitive functions such as learning and memory. The company was founded by Kollol Pal, Frank S. Menniti, and Bertrand Leo Chenard in 2010 and is headquartered in Cambridge, MA. | Health Technology |
| Biotie Therapies, Inc. |
- Borsa valori
- Insiders
- Christopher Kenney
- Esperienza
